You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

azd6738

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Ann Arbor, Detroit, Charlottesville (Olaparib, AZD6738)

Active, not recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +2 more
Jan 9, 2023

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Malignant Melanoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

High Grade Serous Carcinoma Trial in Baltimore, Boston, Philadelphia (Olaparib Pill, AZD6738)

Recruiting
  • High Grade Serous Carcinoma
  • Olaparib Pill
  • AZD6738
  • Baltimore, Maryland
  • +2 more
Mar 4, 2022

Bile Duct Cancer, Chemo Effect Trial in Seoul (AZD6738, Durvalumab)

Recruiting
  • Bile Duct Cancer
  • Chemotherapy Effect
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2021

Cancer Trial in Cambridge (AZD6738, Gemcitabine)

Recruiting
  • Cancer
  • Cambridge, England, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jun 3, 2021

Cancer Trial in United States (AZD2281, AZD5363, AZD1775)

Active, not recruiting
  • Cancer
  • New Haven, Connecticut
  • +3 more
Sep 14, 2021

SCLC Trial in Seoul (AZD6738, Olaparib)

Completed
  • SCLC
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 16, 2021

Bile Duct Cancer, Chemo Effect Trial in Seoul (AZD6738, Durvalumab, Olaparib)

Recruiting
  • Bile Duct Cancer
  • Chemotherapy Effect
  • AZD6738
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2021

Leukemia, Myelodysplastic Syndrome Trial in Boston, Saint Louis (AZD6738)

Recruiting
  • Leukemia
  • Myelodysplastic Syndrome
  • AZD6738
  • Boston, Massachusetts
  • +3 more
Jan 13, 2021

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Gynaecological Cancers Trial in London (AZD6738, Olaparib)

Recruiting
  • Gynaecological Cancers
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Sep 2, 2020

Solid Tumour Refractory to Conventional Treatment Trial in London (AZD6738, Palliative radiotherapy)

Unknown status
  • Solid Tumour Refractory to Conventional Treatment
  • AZD6738
  • Palliative radiotherapy
  • London, United Kingdom
  • +2 more
Apr 7, 2020

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Breast Tumor Trial in United Kingdom (AZD6738, Olaparib, Durvalumab)

Recruiting
  • Breast Neoplasm
  • AZD6738
  • +2 more
  • Bournemouth, Dorset, United Kingdom
  • +8 more
Feb 19, 2020

Advanced Breast Cancer Trial in United Kingdom (Fulvestrant, Neratinib, AZD5363)

Recruiting
  • Advanced Breast Cancer
  • Sutton, England, United Kingdom
  • +18 more
Jan 17, 2019